21-12-2022 15:00 via wallstreet-online.de

Lexaria's DehydraTECH-CBD Achieves Superior Human Blood Absorption Levels

KELOWNA, BC / ACCESSWIRE / December 21, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce it has demonstrated superior cannabidiol ("CBD") …
Weiterlesen »